BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function
Journal article published in 2021 by
Gennaro Daniele,
Clorinda Schettino,
Laura Arenare 
,
Domenico Bilancia,
Fabio Farinati,
Piera Federico,
Stefano Tamberi,
Gino Crivellari,
Sandro Barni,
Raffaella Tortora,
Francesco Izzo,
Antonio Frassoldati,
Luigi Cavanna,
Claudia Mucciarini,
Luigi Bolondi
and other authors.
,
Domenico Bilancia,
Fabio Farinati,
Piera Federico,
Stefano Tamberi,
Gino Crivellari,
Sandro Barni,
Raffaella Tortora,
Francesco Izzo,
Antonio Frassoldati,
Luigi Cavanna,
Claudia Mucciarini,
Luigi Bolondi
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 